Dr. Hendricks Appointed to FDA Drug Advisory Panel

The U.S. Food and Drug Administration has appointed Ed J. Hendricks, M.D., a Sacramento-area obesity treatment specialist, to the FDA Endocrinologic and Metabolic Drug Advisory Committee (EMDAC). The EMDAC is the FDA-selected panel of experts that reviews new drugs for treating obesity, advising the FDA if these drugs should be approved. Dr. Hendricks, who has [...]